nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
author index
|
|
|
|
20 |
S3 |
p. iii49-iii51 |
artikel |
2 |
committees and management
|
|
|
|
20 |
S3 |
p. iii7 |
artikel |
3 |
Editorial Board
|
|
|
|
20 |
S3 |
p. iii-iv |
artikel |
4 |
MDICT Task Force
|
|
|
|
20 |
S3 |
p. iii9 |
artikel |
5 |
NDDO Education Foundation and its partners
|
|
|
|
20 |
S3 |
p. iii8 |
artikel |
6 |
Oral presentations
|
|
|
|
20 |
S3 |
p. iii17-iii26 |
artikel |
7 |
Poster categories and titles
|
|
|
|
20 |
S3 |
p. iii13-iii15 |
artikel |
8 |
posters A: Target identification and validation
|
|
|
|
20 |
S3 |
p. iii27-iii29 |
artikel |
9 |
posters B: Drug design and discovery
|
|
|
|
20 |
S3 |
p. iii30-iii31 |
artikel |
10 |
posters C: Preclinical drug profiles
|
|
|
|
20 |
S3 |
p. iii32-iii35 |
artikel |
11 |
posters D: Apoptosis
|
|
|
|
20 |
S3 |
p. iii36-iii37 |
artikel |
12 |
posters E: Biomarkers
|
|
|
|
20 |
S3 |
p. iii38-iii39 |
artikel |
13 |
posters F: Molecular diagnosis and patient selection
|
|
|
|
20 |
S3 |
p. iii40-iii41 |
artikel |
14 |
posters G: Phase 1 and 2 studies
|
|
|
|
20 |
S3 |
p. iii42-iii44 |
artikel |
15 |
posters H: Other clinical studies
|
|
|
|
20 |
S3 |
p. iii45-iii46 |
artikel |
16 |
Program, Monday, March 23
|
|
|
|
20 |
S3 |
p. iii10 |
artikel |
17 |
Program, Tuesday, March 24
|
|
|
|
20 |
S3 |
p. iii11 |
artikel |
18 |
Program, Wednesday, March 25
|
|
|
|
20 |
S3 |
p. iii12 |
artikel |
19 |
sponsor and grant acknowledgements
|
|
|
|
20 |
S3 |
p. iii6 |
artikel |
20 |
subject index
|
|
|
|
20 |
S3 |
p. iii47-iii48 |
artikel |
21 |
Table of Contents
|
|
|
|
20 |
S3 |
p. v |
artikel |
22 |
Title Page
|
|
|
|
20 |
S3 |
p. ii |
artikel |
23 |
Welcome to TAT 2009
|
|
|
|
20 |
S3 |
p. iii5 |
artikel |